Pertussis Completed Phase 3 Trials for Bordetella pertussis fimbriae 2/3 antigen (DB10790)

Also known as: Whooping cough due to Bordetella pertussis / Whooping Cough / Whooping cough due to bordetella pertussis (B. pertussis)

IndicationStatusPhase
DBCOND0014696 (Pertussis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00255047Safety and Immune Response of Different Pediatric Combination Vaccines.Prevention
NCT00258895Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®Prevention
NCT00467519Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of AgePrevention
NCT00772928Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™Prevention
NCT01346293Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgePrevention